FPTW
BMY icon

Franklin, Parlapiano, Turner & Welch’s Bristol-Myers Squibb BMY Stock Holding History

Franklin, Parlapiano, Turner & Welch’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-100
Closed -$5K – 58
2017
Q1 		$5K Hold
100
– – ﹤0.01% 113
2016
Q4 		$6K Buy
+100
New +$5.47K ﹤0.01% 108

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin, Parlapiano, Turner & Welch's BMY Position: Q2 2017 in Review

Franklin, Parlapiano, Turner & Welch sold out of Bristol-Myers Squibb (BMY) in Q2 2017, closing a stake of 100 shares — an estimated $5K sold.

Franklin, Parlapiano, Turner & Welch first reported a position in BMY in Q4 2016 and held it in 2 quarters. The position peaked at $6K in Q4 2016. 1,595 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

  • Franklin, Parlapiano, Turner & Welch reported no remaining Bristol-Myers Squibb position as of Q2 2017 after selling out during the quarter.
  • Franklin, Parlapiano, Turner & Welch sold 100 Bristol-Myers Squibb shares in Q2 2017, an estimated $5K.
  • Franklin, Parlapiano, Turner & Welch first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 2 quarters.
  • Franklin, Parlapiano, Turner & Welch's Bristol-Myers Squibb position peaked at $6K in Q4 2016.
  • 1,595 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Franklin, Parlapiano, Turner & Welch's 13F filing for Q2 2017, filed 17 Jul 2017.